About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Logout
Obstetrics and Gynegology2022№6
Assessment of ovarian reserve in...

Assessment of ovarian reserve in children and adolescents with Turner’s syndrome

DOI
https://dx.doi.org/10.18565/aig.2022.6.40-49

Uvarova E.V., Turchinets A.I., Kumykova Z.Kh., Pivovarova O.Yu.

1) Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation, Moscow, Russian Federation; 2) I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 3) N.I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Department of Obstetrics and Gynecology, Faculty of Pediatrics, Moscow, Russian Federation
Premature ovarian failure affects the majority of female patients with Turner’s syndrome and therefore only 5–10% is observed to have regular menstruation, whereas spontaneous pregnancy occurs in only 2% of women with this syndrome mostly at a young age and generally in patients with mosaic karyotype. Girls with Turner’s syndrome are noted to have a reduced pool of oogonia in the primary gonads and primordial follicles just at birth, which is concurrent with subsequent postnatal loss of gametes, leads to ovarian reserve depletion before reaching reproductive maturity in 90% of patients. Fertility preservation in this cohort of patients is potentially feasible because many girls with Turner’s syndrome retain ovarian follicles until adolescence. Biochemical markers that reflect childhood ovarian reserve and predict the degree of ovarian impairment are needed to identify candidates among girls and adolescents with Turner’s syndrome, as well as the timing of fertility preservation procedures. The paper reviews current information on the assessment of ovarian reserve in girls with Turner’s syndrome, considers the relationship of the ovarian reserve to the karyotype, and describes the results of ovarian tissue biopsy, as well as the experience with assisted reproductive technologies and cryopreservation to achieve pregnancy in these patients in the future.
Conclusion: An early assessment of ovarian reserve before the age of 10 years should be made, by taking into account the karyotype, FSH, AMH and inhibin B levels, spontaneous menarche and puberty, in order to timely consider possible options for preserving fertility.

Keywords

Turner’s syndrome
ovarian reserve
premature ovarian failure
fertility preservation
cryopreservation
Full text (in Russian)

References

  1. Ye M., Yeh J., Kosteria I., Li L. Progress in fertility preservation strategies in turner syndrome. Front. Med. (Lausanne). 2020; 7: 3. https://dx.doi.org/10.3389/fmed.2020.00003.
  2. Hall J.G., Gilchrist D.M. Turner syndrome and its variants. Pediatr. Clin. North Am. 1990; 37(6): 1421-40. https://dx.doi.org/10.1016/s0031-3955(16)37018-3.
  3. Rizzolio F., Bione S., Sala C., Goegan M., Gentile M., Gregato G. et al. Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Hum. Reprod. 2006; 21(6): 1477-83. https://dx.doi.org/10.1093/humrep/dei495.
  4. Mercer C.L., Lachlan K., Karcanias A., Affara N., Huang S., Jacobs P.A., Thomas N.S. Detailed clinical and molecular study of 20 females with Xq deletions with special reference to menstruation and fertility. Eur. J. Med. Genet. 2013; 56(1): 1-6. https://dx.doi.org/10.1016/j.ejmg.2012.08.012.
  5. Gravholt C.H., Andersen N.H., Conway G.S., Dekkers O.M., Geffner M.E., Klein K.O. et al.; International Turner Syndrome Consensus Group. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur. J. Endocrinol. 2017; 177(3): G1-70. https://dx.doi.org/10.1530/EJE-17-0430.
  6. Quilter C.R., Karcanias A.C., Bagga M.R., Duncan S., Murray A., Conway G.S. et al. Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF). Hum. Reprod. 2010; 25(8): 2139-50. https://dx.doi.org/10.1093/humrep/deq158.
  7. Reynaud K., Cortvrindt R., Verlinde F., De Schepper J., Bourgain C., Smitz J. Number of ovarian follicles in human fetuses with the 45,X karyotype. Fertil. Steril. 2004; 81(4): 1112-9. https://dx.doi.org/10.1016/j.fertnstert.2003.12.011.
  8. Hook E.B., Warburton D. Turner syndrome revisited: review of new data supports the hypothesis that all viable 45,X cases are cryptic mosaics with a rescue cell line, implying an origin by mitotic loss. Hum. Genet. 2014; 133(4): 417-24. https://dx.doi.org/10.1007/s00439-014-1420-x.
  9. Hreinsson J.G., Otala M., Fridström M., Borgström B., Rasmussen C., Lundqvist M. et al. Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J. Clin. Endocrinol. Metab. 2002; 87(8): 3618-23. https://dx.doi.org/10.1210/jcem.87.8.8753.
  10. Borgström B., Hreinsson .J, Rasmussen C., Sheikhi M., Fried G., Keros V. et al. Fertility preservation in girls with turner syndrome: prognostic signs of the presence of ovarian follicles. J. Clin. Endocrinol. Metab. 2009; 94(1): 74-80. https://dx.doi.org/10.1210/jc.2008-0708.
  11. Bernard V., Donadille B., Zenaty D., Courtillot C., Salenave S., Brac de la Perrière A. et al. CMERC Center for Rare Disease. Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum. Reprod. 2016; 31(4): 782-8. https://dx.doi.org/10.1093/humrep/dew012.
  12. Mortensen K.H., Rohde M.D., Uldbjerg N., Gravholt C.H. Repeated spontaneous pregnancies in 45,X Turner syndrome. Obstet. Gynecol. 2010; 115(2, Pt 2): 446-9. https://dx.doi.org/10.1097/AOG.0b013e3181cb5b2a.
  13. Fitz V.W., Law J.R., Peavey M. Karyotype is associated with timing of ovarian failure in women with Turner syndrome. J. Pediatr. Endocrinol. Metab. 2021; 34(3): 319-23. https://dx.doi.org/10.1515/jpem-2020-0304.
  14. Hagen C.P., Main K.M., Kjaergaard S., Juul A. FSH, LH, inhibin B and estradiol levels in Turner syndrome depend on age and karyotype: longitudinal study of 70 Turner girls with or without spontaneous puberty. Hum. Reprod. 2010; 25(12): 3134-41. https://dx.doi.org/10.1093/humrep/deq291.
  15. Carpini S., Carvalho A.B., de Lemos-Marini S.H.V., Guerra-Junior G., Maciel-Guerra A.T. FSH may be a useful tool to allow early diagnosis of Turner syndrome. BMC Endocr. Disord. 2018; 18(1): 8. https://dx.doi.org/10.1186/s12902-018-0236-4.
  16. Johannsen T.H., Main K.M., Ljubicic M.L., Jensen T.K., Andersen H.R., Andersen M.S. et al. Sex differences in reproductive hormones during mini-puberty in infants with normal and disordered sex development. J. Clin. Endocrinol. Metab. 2018; 103(8): 3028-37. https://dx.doi.org/10.1210/jc.2018-00482.
  17. Hamza R.T., Mira M.F., Hamed A.I., Ezzat T., Sallam M.T. Anti-Müllerian hormone levels in patients with turner syndrome: Relation to karyotype, spontaneous puberty, and replacement therapy. Am. J. Med. Genet. A. 2018; 176(9): 1929-34. https://dx.doi.org/10.1002/ajmg.a.40473.
  18. Messina M.F., Aversa T., Salzano G., Costanzo D., Sferlazzas C., Mirabelli S. et al. Inhibin B in adolescents and young adults with Turner syndrome. J. Pediatr. Endocrinol. Metab. 2015; 28(11-12): 1209-14. https://dx.doi.org/10.1515/jpem-2014-0229.
  19. Hagen C.P., Aksglaede L., Sorensen K., Main K.M., Boas M., Cleemann L. et al. Serum levels of anti-Mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J. Clin. Endocrinol. Metab. 2010; 95(11): 5003-10. https://dx.doi.org/10.1210/jc.2010-0930.
  20. Visser J.A., Hokken-Koelega A.C., Zandwijken G.R., Limacher A., Ranke M.B., Flück C.E. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Hum. Reprod. 2013; 28(7): 1899-907. https://dx.doi.org/10.1093/humrep/det089.
  21. Lunding S.A., Aksglaede L., Anderson R.A., Main K.M., Juul A., Hagen C.P., Pedersen A.T. AMH as predictor of premature ovarian insufficiency: A Longitudinal Study of 120 Turner Syndrome Patients. J. Clin. Endocrinol. Metab. 2015; 100(7): E1030-8. https://dx.doi.org/10.1210/jc.2015-1621.
  22. Fechner P.Y., Davenport M.L., Qualy R.L., Ross J.L., Gunther D.F., Eugster E.A. et al.; Toddler Turner Study Group. Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age. J. Clin. Endocrinol. Metab. 2006; 91(12): 4896-902. https://dx.doi.org/10.1210/jc.2006-1157.
  23. Purushothaman R., Lazareva O., Oktay K., Ten S. Markers of ovarian reserve in young girls with Turner's syndrome. Fertil. Steril. 2010; 94(4): 1557-9. https://dx.doi.org/10.1016/j.fertnstert.2009.12.026.
  24. Fernández-García R., García-Doval S., Costoya S., Pásaro E. Analysis of sex chromosome aneuploidy in 41 patients with Turner syndrome: a study of 'hidden' mosaicism. Clin. Genet. 2000; 58(3): 201-8. https://dx.doi.org/10.1034/j.1399-0004.2000.580307.x.
  25. Messina M.F., Aversa T., Salzano G., Costanzo D., Sferlazzas C., Mirabelli S. et al. Inhibin B in adolescents and young adults with Turner syndrome. J. Pediatr. Endocrinol. Metab. 2015; 28(11-12): 1209-14. https://dx.doi.org/10.1515/jpem-2014-0229.
  26. Hankus M., Soltysik K., Szeliga K., Antosz A., Drosdzol-Cop A., Wilk K. et al. Prediction of spontaneous puberty in Turner syndrome based on mid-childhood gonadotropin concentrations, karyotype, and ovary visualization: A Longitudinal Study. Horm. Res. Paediatr. 2018; 89(2): 90-7. https://dx.doi.org/10.1159/000485321.
  27. Hreinsson J.G., Otala M., Fridström M., Borgström B., Rasmussen C., Lundqvist M. et al. Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J. Clin. Endocrinol. Metab. 2002; 87(8): 3618-23. https://dx.doi.org/10.1210/jcem.87.8.8753.
  28. Mamsen L.S., Charkiewicz K., Anderson R.A., Telfer E.E., McLaughlin M., Kelsey T.W. et al. Characterization of follicles in girls and young women with Turner syndrome who underwent ovarian tissue cryopreservation. Fertil. Steril. 2019; 111(6): 1217-25.e3. https://dx.doi.org/10.1016/j.fertnstert.2019.02.003.
  29. Peek R., Schleedoorn M., Smeets D., van de Zande G., Groenman F., Braat D. et al. Ovarian follicles of young patients with Turner's syndrome contain normal oocytes but monosomic 45,X granulosa cells. Hum. Reprod. 2019; 34(9):1686-96. https://dx.doi.org/10.1093/humrep/dez135.
  30. Balen A.H., Harris S.E., Chambers E.L., Picton H.M. Conservation of fertility and oocyte genetics in a young woman with mosaic Turner syndrome. BJOG. 2010; 117(2): 238-42. https://dx.doi.org/10.1111/j.1471-0528.2009.02423.x.
  31. Nadesapillai S., van der Velden J., Smeets D., van de Zande G., Braat D., Fleischer K., Peek R. Why are some patients with 45,X Turner syndrome fertile? A young girl with classical 45,X Turner syndrome and a cryptic mosaicism in the ovary. Fertil. Steril. 2021; 115(5): 1280-7. https://dx.doi.org/10.1016/j.fertnstert.2020.11.006.
  32. McLaughlin E.A., McIver S.C. Awakening the oocyte: controlling primordial follicle development. Reproduction. 2009; 137(1): 1-11. https://dx.doi.org/10.1530/REP-08-0118.
  33. Modi D.N., Sane S., Bhartiya D. Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Mol Hum Reprod. 2003; 9(4): 219-25. https://dx.doi.org/10.1093/molehr/gag031.
  34. Schleedoorn M.J., van der Velden A.A.E.M., Braat D.D.M., Peek R., Fleischer K. To Freeze or Not to Freeze? An update on fertility preservation in females with Turner syndrome. Pediatr. Endocrinol. Rev. 2019; 16(3): 369-82. https://dx.doi.org/10.17458/per.vol16.2019.svb.tofreezeornot.
  35. Talaulikar V.S., Conway G.S., Pimblett A., Davies M.C. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome. Fertil. Steril. 2019; 111(3): 505-9. https://dx.doi.org/10.1016/j.fertnstert.2018.11.010.
  36. Oktay K., Bedoschi G. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments. J. Pediatr. Adolesc. Gynecol. 2014; 27(6): 342-6. https://dx.doi.org/10.1016/j.jpag.2014.01.003.
  37. Strypstein L., Van Moer E., Nekkebroeck J., Segers I., Tournaye H., Demeestere I. et al. First live birth after fertility preservation using vitrification of oocytes in a woman with mosaic Turner syndrome. J. Assist. Reprod. Genet. 2022; 39(2): 543-9. https://dx.doi.org/10.1007/s10815-022-02420-4.
  38. Oktay K., Bedoschi G., Berkowitz K., Bronson R., Kashani B., McGovern P. et al. Fertility preservation in women with Turner syndrome: A comprehensive review and practical guidelines. J. Pediatr. Adolesc. Gynecol. 2016; 29(5): 409-16. https://dx.doi.org/10.1016/j.jpag.2015.10.011.
  39. Huang J.Y., Tulandi T., Holzer H., Lau N.M., Macdonald S., Tan S.L., Chian R.C. Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: case report. Hum. Reprod. 2008; 23(2): 336-9. https://dx.doi.org/10.1093/humrep/dem307.
  40. Jeve Y.B., Gelbaya T., Fatum M. Time to consider ovarian tissue cryopreservation for girls with Turner's syndrome: an opinion paper. Hum Reprod Open. 2019; 2019(3): hoz016. https://dx.doi.org/10.1093/hropen/hoz016.
  41. Donnez J., Dolmans M.M., Demylle D., Jadoul P., Pirard C., Squifflet J. et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004; 364(9443): 1405-10. https://dx.doi.org/10.1016/S0140-6736(04)17222-X.
  42. Schleedoorn M., van der Velden J., Braat D., Beerendonk I., van Golde R., Peek R. et al. Turner fertility trial: PROTOCOL for an observational cohort study to describe the efficacy of ovarian tissue cryopreservation for fertility preservation in females with Turner syndrome. BMJ Open. 2019; 9(12): e030855. https://dx.doi.org/10.1136/bmjopen-2019-030855.
  43. Dolmans M.M., Falcone T., Patrizio P. Importance of patient selection to analyze in vitro fertilization outcome with transplanted cryopreserved ovarian tissue. Fertil. Steril. 2020; 114(2):279-80. https://dx.doi.org/10.1016/j.fertnstert.2020.04.050.
  44. Poirot C., Brugieres L., Yakouben K., Prades-Borio M., Marzouk F., de Lambert G. et al. Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center. Acta Obstet. Gynecol. Scand. 2019; 98(5): 630-7. https://dx.doi.org/10.1111/aogs.13616.
  45. Corkum K.S., Rhee D.S., Wafford Q.E., Demeestere I., Dasgupta R., Baertschiger R. et al. Fertility and hormone preservation and restoration for female children and adolescents receiving gonadotoxic cancer treatments: a systematic review. J. Pediatr. Surg. 2019; 54(11): 2200-9. https://dx.doi.org/10.1016/j.jpedsurg.2018.12.021.
  46. Gellert S.E., Pors S.E., Kristensen S.G., Bay-Bjørn A.M., Ernst E., Yding Andersen C. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J. Assist. Reprod. Genet. 2018; 35(4): 561-70. https://dx.doi.org/10.1007/s10815-018-1144-2.
  47. Demeestere I., Simon P., Dedeken L., Moffa F., Tsepelidis S., Brachet C. et al. Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum. Reprod. 2015; 30(9): 2107-9. https://dx.doi.org/10.1093/humrep/dev128.
  48. База данных клинических исследований, финансируемых из частных и государственных источников по всему миру, ClinicalTrials.gov. [Database of clinical trials funded from private and public sources around the world, ClinicalTrials.gov]. Available at: https://clinicaltrials.gov/ct2/show/NCT01410045
  49. База данных клинических исследований, финансируемых из частных и государственных источников по всему миру, ClinicalTrials.gov. [Database of clinical trials funded from private and public sources around the world, ClinicalTrials.gov]. Available at: https://clinicaltrials.gov/ct2/show/NCT03381300
  50. База данных клинических исследований, финансируемых из частных и государственных источников по всему миру, ClinicalTrials.gov. [Database of clinical trials funded from private and public sources around the world, ClinicalTrials.gov]. Available at: https://clinicaltrials.gov/ct2/show/NCT04189406

Received 21.03.2022

Accepted 28.03.2022

About the Authors

Elena V. Uvarovа, Corresponding Member of the RAS, Dr. Med. Sci., Professor at the Department of Obstetrics, Gynecology and Perinatology, First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); Head of the Department of Pediatric and Adolescent Gynecology, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, elena-uvarova@yandex.ru, https://orcid.org/0000-0002-3105-5640,
117997, Russia, Moscow, Ac. Oparin str., 4.
Anna I. Turchinets, resident at the Department of Obstetrics and Gynecology, Pediatric Faculty, Pirogov Russian National Research Medical University, Ministry of Health of Russia, +7(926)522-87-39, Ponomarevaanna28@gmail.com, https://orcid.org/0000-0002-4478-9133, 117997, Russia, Moscow, Ostrovitianov str., 1.
Zaira Kh. Kumykova, PhD, Senior Researcher at the Departament of Pediatric and Adolescent Gynecology, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, zai-kumykova@yandex.ru, https://orcid.org/0000-0001-7511-1432,
117997, Russia, Moscow, Ac. Oparin str., 4.
Oksana Yu. Pivovarova, PhD, Associate Professor at the Department of Obstetrics and Gynecology, Pediatric Faculty, Pirogov Russian National Research Medical University, Ministry of Health of Russia, pou@mail.ru, https://orcid.org/0000-0002-8957-3248, 117997, Russia, Moscow, Ostrovitianov str., 1.
Corresponding author: Anna I. Turchinets, Ponomarevaanna28@gmail.com

Authors' contributions: Uvarova E.V., Turchinets A.I. – concept and design of the investigation, data analysis; Pivovarova O.Yu., Turchinets A.I. – material collection and processing; Kumykova Z.Kh., Turchinets A.I. – writing the text; Uvarova E.V., Kumykova Z.Kh., Pivovarova O.Yu. – editing.
Conflicts of interest: The authors declare that there are no conflicts of interest.
Funding: The investigation has been conducted without additional funding.
For citation: Uvarova E.V., Turchinets A.I., Kumykova Z.Kh., Pivovarova O.Yu.
Assessment of ovarian reserve in children and adolescents with Turner’s syndrome.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2022; 6: 40-49 (in Russian)
https://dx.doi.org/10.18565/aig.2022.6.40-49

Similar Articles

№11 / 2021
Dmitrieva I.E., Nazarenko T.A., Burduli A.G., Polushkina E.S., Khokhlova S.V.
Fertility outcomes in women after therapy for non-Hodgkin lymphoma
№12 / 2020
Bondarenko K.R., Dobrokhotova Yu.E., Nasyrova N.I., Shadrova P.A.
Estrogen therapy: from science to practical solutions
№8 / 2021
Bondarenko K.R., Dobrokhotova Yu.E.
Clinical masks of secondary amenorrhea: treatment of the disease rather than its symptom
№11 / 2020
Bichevaya N.K., Leontyeva O.A., Saifitdinova A.F., Pastukhova Yu.R., Kuznetsova R.A., Nevskaya E.E., Reshetnikov I.V., Panina A.N., Samoilovich Ya.A., Pashina O.B., Puppo I.L., Isakova E.V.
Use of donor gametes and embryos for the treatment of infertility
№6 / 2024
Martirosyan Ya.O., Nazarenko T.A., Kadaeva A.I., Goryunov K.V., Shevtsova Yu.A.
Activation of ovarian function in patients with diminished ovarian reserve through administration of extracellular vesicles
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.